Huberman: Low-dose GLP-1 Use Is Actively Being Explored For Cognitive Well-being
In a conversation with Tim Ferriss, neuroscientist and podcaster Dr. Andrew Huberman turned his attention to a developing area within the peptide space: the use of low-dose GLP-1 receptor agonists,…



















